Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Burcon NutraScience Co. stock logo
BU
Burcon NutraScience
C$0.22
+7.5%
C$0.23
C$0.10
C$0.35
C$30.54M2.3839,969 shs32,623 shs
NewMarket Co. stock logo
NEU
NewMarket
$588.51
+0.4%
$615.45
$362.16
$650.00
$5.64B0.4543,146 shs34,556 shs
Resverlogix Corp. stock logo
RVX
Resverlogix
C$0.06
C$0.06
C$0.05
C$0.16
C$14.97M0.7837,274 shs13,500 shs
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Burcon NutraScience Co. stock logo
BU
Burcon NutraScience
+7.50%-12.24%-21.82%+19.44%-15.69%
NewMarket Co. stock logo
NEU
NewMarket
+0.37%-0.96%-5.97%-0.69%+59.38%
Resverlogix Corp. stock logo
RVX
Resverlogix
0.00%-8.33%-8.33%-15.38%-66.67%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Burcon NutraScience Co. stock logo
BU
Burcon NutraScience
N/AN/AN/AN/AN/AN/AN/AN/A
NewMarket Co. stock logo
NEU
NewMarket
1.4905 of 5 stars
0.03.01.70.02.73.31.3
Resverlogix Corp. stock logo
RVX
Resverlogix
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Burcon NutraScience Co. stock logo
BU
Burcon NutraScience
N/AN/AN/AN/A
NewMarket Co. stock logo
NEU
NewMarket
N/AN/AN/AN/A
Resverlogix Corp. stock logo
RVX
Resverlogix
N/AN/AN/AN/A

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Burcon NutraScience Co. stock logo
BU
Burcon NutraScience
C$324.55K94.09C$0.01 per share39.00C$0.02 per share10.75
NewMarket Co. stock logo
NEU
NewMarket
$2.70B2.09$48.88 per share12.04$112.31 per share5.24
Resverlogix Corp. stock logo
RVX
Resverlogix
N/AN/AC$0.00 per share132.50C($0.26) per shareN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Burcon NutraScience Co. stock logo
BU
Burcon NutraScience
-C$7.21M-C$0.21N/AN/AN/A-169.75%-45.14%6/26/2024 (Estimated)
NewMarket Co. stock logo
NEU
NewMarket
$388.86M$40.4314.56N/A14.41%41.33%16.70%4/24/2024 (Confirmed)
Resverlogix Corp. stock logo
RVX
Resverlogix
-C$12.82M-C$0.05N/AN/AN/AN/A-37.10%5/9/2024 (Estimated)

Latest BU, NEU, RVX, and TILS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/24/2024N/A
NewMarket Co. stock logo
NEU
NewMarket
N/AN/AN/AN/AN/AN/A  
2/14/2024Q3 2024
Burcon NutraScience Co. stock logo
BU
Burcon NutraScience
N/A-C$0.02-C$0.02-C$0.02N/AN/A
1/31/2024Q4 2023
NewMarket Co. stock logo
NEU
NewMarket
N/A$8.38+$8.38$8.38N/A$643.35 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Burcon NutraScience Co. stock logo
BU
Burcon NutraScience
N/AN/AN/AN/AN/A
NewMarket Co. stock logo
NEU
NewMarket
$10.001.70%+5.21%24.73%2 Years
Resverlogix Corp. stock logo
RVX
Resverlogix
N/AN/AN/AN/AN/A

Latest BU, NEU, RVX, and TILS Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/22/2024
NewMarket Co. stock logo
NEU
NewMarket
Quarterly$2.501.58%3/14/20243/15/20244/1/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Burcon NutraScience Co. stock logo
BU
Burcon NutraScience
190.99
1.63
1.71
NewMarket Co. stock logo
NEU
NewMarket
0.60
2.85
1.60
Resverlogix Corp. stock logo
RVX
Resverlogix
N/A
0.11
0.04

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Burcon NutraScience Co. stock logo
BU
Burcon NutraScience
0.33%
NewMarket Co. stock logo
NEU
NewMarket
61.09%
Resverlogix Corp. stock logo
RVX
Resverlogix
N/A

Insider Ownership

CompanyInsider Ownership
Burcon NutraScience Co. stock logo
BU
Burcon NutraScience
29.93%
NewMarket Co. stock logo
NEU
NewMarket
20.40%
Resverlogix Corp. stock logo
RVX
Resverlogix
43.19%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Burcon NutraScience Co. stock logo
BU
Burcon NutraScience
24142.03 millionN/ANot Optionable
NewMarket Co. stock logo
NEU
NewMarket
2,0009.59 million7.63 millionOptionable
Resverlogix Corp. stock logo
RVX
Resverlogix
19272.17 millionN/ANot Optionable

BU, NEU, RVX, and TILS Headlines

SourceHeadline
Resverlogix Announces Change to Its Board of DirectorsResverlogix Announces Change to Its Board of Directors
finance.yahoo.com - February 21 at 8:02 PM
Resverlogix Announces Publication of its 40th Scientific Journal Article on Apabetalones Potential Therapeutic BenefitsResverlogix Announces Publication of its 40th Scientific Journal Article on Apabetalone's Potential Therapeutic Benefits
finance.yahoo.com - January 11 at 10:03 AM
Closing Bell: Resverlogix Corp flat on Tuesday (RVX)Closing Bell: Resverlogix Corp flat on Tuesday (RVX)
theglobeandmail.com - January 4 at 6:16 PM
Resverlogix Corp. (RVX) Earnings Dates & ReportsResverlogix Corp. (RVX) Earnings Dates & Reports
investing.com - December 19 at 7:28 PM
Resverlogix Corp RVXCFResverlogix Corp RVXCF
morningstar.com - November 18 at 5:49 PM
Resverlogix Corp RVXResverlogix Corp RVX
morningstar.com - November 1 at 11:18 AM
Resverlogix: Top 10 Undervalued Healthcare Sector Stocks on TSX (RVX)Resverlogix: Top 10 Undervalued Healthcare Sector Stocks on TSX (RVX)
theglobeandmail.com - October 18 at 7:46 AM
Resverlogix Corp.: Resverlogix Publishes on Apabetalones Potential for the Treatment of FSHD, the Third Most Common Muscular DystrophyResverlogix Corp.: Resverlogix Publishes on Apabetalone's Potential for the Treatment of FSHD, the Third Most Common Muscular Dystrophy
finanznachrichten.de - October 4 at 10:11 AM
Resverlogix Publishes on Apabetalones Potential for the Treatment of FSHD, the Third Most Common Muscular DystrophyResverlogix Publishes on Apabetalone's Potential for the Treatment of FSHD, the Third Most Common Muscular Dystrophy
finance.yahoo.com - October 4 at 10:11 AM
Atherosclerotic Cardiovascular Disease Market to Observe Impressive Growth at a CAGR of 2.2% by 2032, Predicts DelveInsightAtherosclerotic Cardiovascular Disease Market to Observe Impressive Growth at a CAGR of 2.2% by 2032, Predicts DelveInsight
finance.yahoo.com - September 26 at 8:50 PM
Resverlogix Announces a Favorable Outlook Based on New Cardiovascular Disease Treatment Guidelines for Patients with Type 2 DiabetesResverlogix Announces a Favorable Outlook Based on New Cardiovascular Disease Treatment Guidelines for Patients with Type 2 Diabetes
finance.yahoo.com - August 29 at 10:13 AM
Closing Bell: Resverlogix Corp up on Wednesday (RVX)Closing Bell: Resverlogix Corp up on Wednesday (RVX)
theglobeandmail.com - August 24 at 3:35 PM
Closing Bell: Resverlogix Corp flat on Monday (RVX)Closing Bell: Resverlogix Corp flat on Monday (RVX)
theglobeandmail.com - August 14 at 10:02 PM
Closing Bell: Resverlogix Corp Warrants down on Wednesday (RVX-WT-A)Closing Bell: Resverlogix Corp Warrants down on Wednesday (RVX-WT-A)
theglobeandmail.com - July 12 at 7:21 AM
Resverlogix Announces Warrant Repricing and One-Year ExtensionResverlogix Announces Warrant Repricing and One-Year Extension
finance.yahoo.com - June 29 at 11:09 PM
Resverlogix Corp.: Resverlogix Announces Voting Results from the 2023 Meeting of ShareholdersResverlogix Corp.: Resverlogix Announces Voting Results from the 2023 Meeting of Shareholders
finanznachrichten.de - June 20 at 7:31 PM
Resverlogix Announces Voting Results from the 2023 Meeting of ShareholdersResverlogix Announces Voting Results from the 2023 Meeting of Shareholders
finance.yahoo.com - June 20 at 7:31 PM
Resverlogix Announces New Insights into the Mechanism of Apabetalones Cardioprotective Benefit in Chronic Kidney Disease PatientsResverlogix Announces New Insights into the Mechanism of Apabetalone's Cardioprotective Benefit in Chronic Kidney Disease Patients
finance.yahoo.com - June 12 at 6:42 PM
Canadian Investment Regulatory Organization Trading Halt - RVX.WT.ACanadian Investment Regulatory Organization Trading Halt - RVX.WT.A
finance.yahoo.com - June 7 at 1:32 PM
Closing Bell: Resverlogix Corp Warrants down on Friday (RVX-WT-A)Closing Bell: Resverlogix Corp Warrants down on Friday (RVX-WT-A)
theglobeandmail.com - June 6 at 10:49 AM
Closing Bell: Resverlogix Corp Warrants down on Tuesday (RVX-WT-A)Closing Bell: Resverlogix Corp Warrants down on Tuesday (RVX-WT-A)
theglobeandmail.com - May 25 at 12:52 AM
CBOE RUSSELL 2000 VOLATILITY IN (^RVX)CBOE RUSSELL 2000 VOLATILITY IN (^RVX)
finance.yahoo.com - May 18 at 12:38 AM
Bromodomain Containing Protein 2 Market is Likely to Upsurge at ... - StreetBuzzBromodomain Containing Protein 2 Market is Likely to Upsurge at ... - StreetBuzz
news.google.com - May 13 at 3:47 PM
Resverlogix : MD&A Q1 2023 - Marketscreener.comResverlogix : MD&A Q1 2023 - Marketscreener.com
news.google.com - May 12 at 3:50 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Burcon NutraScience logo

Burcon NutraScience

TSE:BU
Burcon NutraScience Corporation, together with its subsidiaries, develops plant proteins and ingredients for use in the food and beverage industries in Canada. The company offers Peazazz and Peazac, a pea protein for use in dairy alternatives, ready-to-drink beverages, dry blended beverages, bars, baked goods, and meat substitute products. It provides Puratein, a canola protein isolate for use in meat alternatives, such as burgers, sausages, and nutrition bars; Supertein, a canola protein that is a light-colored powder for use in non-dairy frozen desserts, egg alternative, plant-based marshmallows and ready-to-mix beverages, whipped toppings, and plant-based bars; and Nutratein, a canola protein comprising a mixture of globulin and albumin proteins for use in meat and egg alternatives, and other plant-based functional foods. In addition, the company offers Nutratein-PS, a blend of Peazazz pea protein and Supertein canola protein; Nutratein-TZ, a blend of Peazac pea protein and Puratein canola protein; and CLARISOY, a soy protein for use in sports nutrition beverages, citrus-based drinks, fruit-flavored beverages, lemonades, powdered beverage mixes, and non-beverage plant-based products. The company was formerly known as Burcon Capital Corp. and changed its name to Burcon NutraScience Corporation in October 1999. The company was incorporated in 1998 and is headquartered in Vancouver, Canada.
NewMarket logo

NewMarket

NYSE:NEU
NewMarket Corporation, through its subsidiaries, primarily engages in the manufacture and sale of petroleum additives. The company offers lubricant additives for use in various vehicle and industrial applications, including engine oils, transmission fluids, off-road powertrain and hydraulic systems, gear oils, hydraulic oils, turbine oils, and other applications where metal-to-metal moving parts are utilized; engine oil additives designed for passenger cars, motorcycles, on and off-road heavy duty commercial equipment, locomotives, and engines in ocean-going vessels; driveline additives designed for products, such as transmission fluids, axle fluids, and off-road powertrain fluids; and industrial additives designed for products for industrial applications consisting of hydraulic fluids, grease, industrial gear fluids, and industrial specialty applications, such as turbine oils. It also provides fuel additives that are used to enhance the oil refining process and the performance of gasoline, diesel, biofuels, and other fuels to industry, government, original equipment manufacturers, and individual customers. In addition, the company engages in the marketing of antiknock compounds, as well as contracted manufacturing and services activities; and owns and manages a real property in Virginia. It operates in North America, Latin America, Asia Pacific, Europe, the Middle East, Africa, and India. NewMarket Corporation was founded in 1887 and is headquartered in Richmond, Virginia.
Resverlogix logo

Resverlogix

TSE:RVX
Resverlogix Corp., a late-stage clinical biotechnology company, develops therapeutics for disease states with high unmet medical needs. Its lead drug is apabetalone (RVX-208), a small molecule selective bromodomain and extra-terminal inhibitor that is in Phase III clinical trial for patients with cardiovascular disease, diabetes mellitus, chronic kidney disease, end-stage renal disease, and neurodegenerative diseases. Resverlogix Corp. has a partnership with Eversana Life Science Services, LLC to support the pending launch of the commercialization of apabetalone for Covid-19 in the United States and Canada; and developing cardiovascular and pulmonary arterial hypertension indications. The company was founded in 2001 and is headquartered in Calgary, Canada.